To address these early and late aspects , @ patients presenting with acute or stable coronary disease needing stents @ mm in diameter between April @ and May @ were randomly assigned to biolimus-A@-eluting BP-DES , second-generation everolimus-eluting DP-DES , or thin-strut silicon-carbide-coated BMS in @ European centers .